ARCHIVES

NCI Issues Statement On Endostatin Research

This article is from The Cancer Letter archive.

Vol. 25 No. 37 | October 1, 1999

Download PDF Visit The Full Archive

Related Articles

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

New NCI Director Plans Greater Support For Translational Research, Collaboration.

March 1, 2002

NCI “Can’t Justify Size Of Intramural Program”

May 12, 1995

Research Triangles Lands Plant Drug Contract Renewal

April 9, 1976

House Aims to End Budget Markup Early; Natcher Sees Most Difficult Year

June 26, 1992

Freshman Congressman Launches Drive for “Adequate” Cancer Research Funding

August 5, 1983